AI Noise Reduction in Phonak Hearing Aids
Launched by MAYO CLINIC · Dec 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using artificial intelligence (AI) to reduce background noise can help people with hearing loss hear better and understand speech more clearly. Researchers want to see if this new technology in Phonak hearing aids makes a noticeable difference for those who struggle to hear in noisy environments.
The study is currently looking for participants aged 40 to 75, including those who have hearing loss and do not currently use hearing aids, those who already use hearing aids, and individuals with a cochlear implant in one ear who also use a hearing aid in the other ear. If you decide to join the trial, you can expect to test the AI-enabled hearing aids and provide feedback on your hearing experience. This is an exciting opportunity to help improve hearing aid technology for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with hearing impairment not using hearing aids
- • Individuals with hearing impairment currently using hearing aids
- • Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Aniket Saoji, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported